Filing Details
- Accession Number:
- 0001209191-15-008639
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-03 14:36:21
- Reporting Period:
- 2015-02-02
- Filing Date:
- 2015-02-03
- Accepted Time:
- 2015-02-03 14:36:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1198230 | J Martha Demski | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham NC 27713 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-02 | 2,000 | $1.53 | 2,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-02 | 2,000 | $38.38 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-02-02 | 2,000 | $0.00 | 2,000 | $1.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 17,126 | 2018-06-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 14,788 | Indirect | By the Martha J. Demski Trust u/a 10/01/94 |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on September 15, 2014.
- The range of sale prices received is $37.86 to $39.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- Immediately exercisable.
Billionaire Hedge Funds
